This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kohonen-Corish, M. R. J. Articles by Dahlstrom, J. E. Search for Related Content PubMed PubMed Citation Articles by Kohonen-Corish, M. R. J. Articles by Dahlstrom, J. E.

Susceptibility of Msh2-deficient Mice to Inflammation-associated Colorectal Tumors¹

Department of Medicine, University of Sydney, Sydney, NSW 2006 & Division of Molecular Medicine, John Curtin School of Medical Research, Canberra, ACT 0200, Australia [M. R. J. K-C.]; Department of Molecular and Clinical Genetics, Royal Prince Alfred Hospital, Sydney, NSW 2050, Australia [J. J. D.]; The Netherlands Cancer Institute, 1066 cx Amsterdam, the Netherlands [H. t. R.]; and The Canberra Clinical School, University of Sydney [G. D. B., J. E. D.] and ACT Pathology [J. E. D.], The Canberra Hospital, Canberra, ACT 2605, Australia

Patients with longstanding extensive ulcerative colitis have an increased risk of developing colorectal cancer (CRC). There are significant differences in the early pathogenesis of colitis-associated tumors compared with common CRC, whereas the frequency, degree, and significance of microsatellite instability (MSI) as a marker of mismatch repair deficiency in colitis tumors remain unclear. Here we describe the application of the DSS model of chronic colitis to mice with a defect in the Msh2 mismatch repair gene to discern these early events. These mice do not develop CRC spontaneously without an external trigger. The aim of this study was to determine the effect of the Msh2 defect on the frequency and grade of colitis-associated colorectal dysplasia and adenocarcinoma in Msh2^-/-, Msh2^+/-, and wild-type (Msh2^+/+) mice and on the MSI status of the tumors. We show that in mice with chronic colitis, 60% of the Msh2^-/- and 29% of the wild-type mice developed high-grade dysplasia or adenocarcinoma, but heterozygosity for the Msh2 defect did not increase tumor susceptibility over wild-type genotype. The largest difference between genotypes was in the frequency of high-grade dysplasia, with 46.7, 8, and 12.5% in Msh2^-/-, Msh2^+/-, and Msh2^+/+ mice, respectively. The Msh2^-/- mice developed MSI-high tumors, whereas the majority of the Msh2^+/- and wild-type tumors had no MSI. In the Msh2^-/- mice, MSI appeared early in non-neoplastic colon tissue, presumably as a result of markedly increased epithelial cell proliferation associated with inflammation. These observations suggest that a homozygous mismatch repair defect predisposes to tumors triggered by chronic inflammation but is not the only factor involved because tumors also developed in the wild-type mice. This model of colitis offers opportunities to characterize the different molecular pathways of carcinogenesis operating in chronic colitis.

This article has been cited by other articles:

				A. M. Westbrook, B. Wei, J. Braun, and R. H. Schiestl Intestinal Mucosal Inflammation Leads to Systemic Genotoxicity in Mice Cancer Res., June 1, 2009; 69(11): 4827 - 4834. [Abstract] [Full Text] [PDF]

				A. E. Snook, P. Li, B. J. Stafford, E. J. Faul, L. Huang, R. C. Birbe, A. Bombonati, S. Schulz, M. J. Schnell, L. C. Eisenlohr, et al. Lineage-Specific T-Cell Responses to Cancer Mucosa Antigen Oppose Systemic Metastases without Mucosal Inflammatory Disease Cancer Res., April 15, 2009; 69(8): 3537 - 3544. [Abstract] [Full Text] [PDF]

				L. Roncucci, E. Mora, F. Mariani, S. Bursi, A. Pezzi, G. Rossi, M. Pedroni, D. Luppi, L. Santoro, S. Monni, et al. Myeloperoxidase-Positive Cell Infiltration in Colorectal Carcinogenesis as Indicator of Colorectal Cancer Risk Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2291 - 2297. [Abstract] [Full Text] [PDF]

				J Barwell, L Pangon, S Hodgson, A Georgiou, I Kesterton, T Slade, M Taylor, S J Payne, H Brinkman, J Smythe, et al. Biallelic mutation of MSH2 in primary human cells is associated with sensitivity to irradiation and altered RAD51 foci kinetics J. Med. Genet., August 1, 2007; 44(8): 516 - 520. [Abstract] [Full Text] [PDF]

				D. Weichart, J. Gobom, S. Klopfleisch, R. Hasler, N. Gustavsson, S. Billmann, H. Lehrach, D. Seegert, S. Schreiber, and P. Rosenstiel Analysis of NOD2-mediated Proteome Response to Muramyl Dipeptide in HEK293 Cells J. Biol. Chem., January 27, 2006; 281(4): 2380 - 2389. [Abstract] [Full Text] [PDF]

				S. H. Itzkowitz and X. Yio Inflammation and Cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G7 - G17. [Abstract] [Full Text] [PDF]

				D. N. Seril, J. Liao, G.-Y. Yang, and C. S. Yang Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models Carcinogenesis, March 1, 2003; 24(3): 353 - 362. [Abstract] [Full Text] [PDF]